GlassScriptPhysician profile
Arusha A Bavare
NPI 1730127770
$1,908.38
in general payments reported to CMS, 2019-2025
32 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $401 · 2021: $130 · 2022: $45.96 · 2023: $300 · 2024: $453 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $941.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $298.12 | 2019-2025 | Lifevest |
| Silk Road Medical, INC. | $182.66 | 2020 | |
| Pfizer INC. | $175.77 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $171.51 | 2019-2023 | Xarelto |
| Sunovion Pharmaceuticals INC. | $102.05 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $98.29 | 2020-2024 | Farxiga |
| Pulmonx Corporation | $91.69 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Sumitomo Pharma America, INC. | $74.84 | 2023 | Gemtesa |
| Lundbeck LLC | $61.65 | 2023-2024 | Rexulti |
| Axonics, INC. | $61.07 | 2023-2024 | Axonics |
| Merck Sharp & Dohme LLC | $59.49 | 2021-2023 | Dificid |
| Bayer Healthcare Pharmaceuticals INC. | $55.22 | 2024 | |
| Eisai INC. | $53.94 | 2023-2024 | |
| Boston Scientific Corporation | $44.98 | 2019-2021 | |
| Smith+Nephew, INC. | $41.73 | 2021-2025 | Collagenase Santyl |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $37.51 | 2023 | Eterna |
| Biotronik Nro, INC. | $32.33 | 2025 | Prospera |
| E.R. Squibb & Sons, L.L.C. | $25.61 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $24.68 | 2024 | Rexulti |
| Allergan, INC. | $20.45 | 2020 | |
| Corium, LLC | $19.16 | 2023 | Adlarity |
| Exact Sciences Corporation | $18.80 | 2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.42 | 2024 | Xifaxan |
| Philips North America LLC | $18.30 | 2020 | |
| Avanir Pharmaceuticals, INC. | $17.22 | 2022 | |
| Viatris Specialty LLC | $16.91 | 2025 | Yupelri |
| Scilex Pharmaceuticals INC. | $16.68 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $15.79 | 2019 | |
| Vifor Pharma, INC. | $14.77 | 2023 | Veltassa |
| Novartis Pharmaceuticals Corporation | $14.11 | 2020 | |
| Astellas Pharma US INC | $12.49 | 2022 | |
| Abbvie INC. | $12.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arusha Bavare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.